News

A new neurodevelopmental disorder has been described

SSM Calls for the Undergraduate and PhD Programs

The Scuola Superiore Meridionale (SSM) announces a public competition for admission to the Undergraduate and PhD programs for the academic year 2023/24!

SEMM Calls for PhD Programs

The European School of Molecular Medicine (SEMM) offers 70 PhD positions in the Systems Medicine program!

Francesca Cervellini was awarded a travel grant by EMBO to attend to the workshop "Lipid droplets: Metabolic hubs in health and disease"

A large international investment in hereditary retinal diseases

The path of AAVantgarde Bio, the Tigem spin-off dedicated to the development of gene therapies for hereditary diseases of the retina, continues at full speed! The company, founded in 2021 thanks to the Sofinnova-Telethon fund, has in fact announced that it has obtained a 61 million euro from three major international investment companies: Atlas Venture, Forbion and Longwood. AAVantgarde Bio will work to bring an innovative gene therapy approach born in the Telethon laboratories to the clinic.

EUROPEAN RESEARCH COUNCIL (ERC): ASSIGNED TO ANDREA BALLABIO AND ALBERTO AURICCHIO TWO ADVANCED GRANTS FOR A TOTAL OF 5 MILLION EUROS

Andrea Ballabio and Alberto Auricchio received the prestigious ERC Advanced Grants, also as evidence of excellence of the Telethon Institute of Genetics and Medicine, capable of attracting the best Italian and international scientists.